Importantly, 100% (n = 7/7) of patients with synchronous CRC showed EPAS1 DNA amplification, whereas only 60% (n = 45/75) of patients without synchronous CRC showed EPAS1 DNA amplification (p = 0.03; Table 1). The gene discussed is EPAS1; the disease is colorectal carcinoma.